References
- Wojnarowska F. Linear IgA disease of adults. Management of blistering diseases, F Wojnarowska, R A Briggaman. Chapman and Hall, London 1990; 105–18
- Jones Russell R, Goolamali S K. IgA bullous pemphigoid: a distinct blistering disorder. Br J Dermatol 1980; 102: 719–25
- Lawley T J, Strober W, Yaoita H, et al. Small intestinal biopsies and HLA types in dermatitis herpetiformis patients with granular and linear IgA deposits. J Invest Dermatol 1980; 74: 9–12
- Stendahl O, Molin L, Dahlgren C. The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone. J Clin Invest 1978; 62: 214–20
- Schifferli J A, Jones Russell R. Dapsone and complement. Lancet 1981; ii: 368–9, (letter)
- Hutchison H E, Jackson J M, Cassidy P. Drug-induced haemolytic anaemia in dermatitis herpetiformis. Br J Dermatol 1963; 75: 161–6
- Degowin R L, Eppes R B, Powell R D, et al. The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency. Bull WHO 1966; 35: 165–79
- Yaoita H, Hertz K C, Katz S I. Dermatitis herpetiformis: immunoelectronmicroscopic and ultrastructural studies of a patient with linear deposition of IgA. J Invest Dermatol 1976; 67: 691–5
- McKenna W B, Chalmers A C. Agranulocytosis following dapsone therapy. Br Med J 1958; i: 324–5
- McFadden J P, Leonard J N, Powles A V, et al. Sulphamethoxypyridazine for dermatitis herpetiformis. linear IgA disease and cicatricial pemphigoid. Br J Dermatol 1989; 121: 759–62
- Aram H. Linear IgA bullous dermatosis: successful treatment with colchicine. Arch Dermatol 1984; 120: 960–1
- Dahl M V. Chemotaxis. Arch Dermatol 1979; 115: 1407–8
- Lever W F. Pemhigus and pemphigoid. J Am Acad Dermatol 1979; 1: 2–31
- Gruber G G, Owen L G, Callen J P. Vesicular pemphigoid. J Am Acad Dermatol 1980; 3: 619–22
- Gupta A K, Brown M D, Ellis C N, et al. Cyclosporine in dermatology. J Am Acad Dermatol 1989; 21: 1245–56
- Ryffel B. Pharmacology of cyclosporine VI. Cellular activation: regulation of intracellular events by cyclosporine. Pharmacol Rev 1989; 41: 407–22
- Borel J F. Pharmacology of cyclosporine (Sandimmun) IV. Pharmacological properties in vivo. Pharmacol Rev 1989; 41: 259–71
- Thomson A W, Nield G H. Cyclosporin: use outside transplantation. Br Med J 1991; 302: 4–5
- Bertault-Peres P, Bonfils C, Fabre G, et al. Metabolism of cyclosporin A. II. Implication of the macrolide antibiotic inducible cytochrome P-450 3c from rabbit liver microsomes. Drug Metab Dispos 1987; 15: 391–8
- Korstanje M J, van Breda Vriesman C JP, van de Staak W JBM. Cyclosporine and methotrexate: a dangerous combination. J Am Acad Dermatol 1990; 23: 320–1
- Savage C OS, Banks I, Pusey C D. Therapeutic applications of plasma exchange. Br J Hosp Med 1988; 40: 272–81